ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $81,309 | +21.8% | 88,054 | +0.1% | 0.00% | – |
Q1 2023 | $66,737 | -69.8% | 87,985 | -0.0% | 0.00% | – |
Q4 2022 | $220,875 | +81.0% | 87,998 | 0.0% | 0.00% | – |
Q3 2022 | $122,000 | +3.4% | 87,998 | -5.8% | 0.00% | – |
Q2 2022 | $118,000 | -57.2% | 93,381 | -1.9% | 0.00% | – |
Q1 2022 | $276,000 | +27.2% | 95,233 | -0.1% | 0.00% | – |
Q4 2021 | $217,000 | -11.1% | 95,343 | +0.0% | 0.00% | – |
Q3 2021 | $244,000 | -10.6% | 95,342 | 0.0% | 0.00% | – |
Q2 2021 | $273,000 | -8.1% | 95,342 | 0.0% | 0.00% | – |
Q1 2021 | $297,000 | +18.8% | 95,342 | 0.0% | 0.00% | – |
Q4 2020 | $250,000 | +127.3% | 95,342 | +149.4% | 0.00% | – |
Q3 2020 | $110,000 | -20.3% | 38,223 | -5.2% | 0.00% | – |
Q2 2020 | $138,000 | +43.8% | 40,312 | -16.1% | 0.00% | – |
Q1 2020 | $96,000 | -52.9% | 48,073 | -5.7% | 0.00% | – |
Q4 2019 | $204,000 | -37.4% | 50,982 | -50.1% | 0.00% | – |
Q3 2019 | $326,000 | -7.4% | 102,244 | +13.3% | 0.00% | – |
Q2 2019 | $352,000 | -68.3% | 90,204 | +97.4% | 0.00% | – |
Q1 2019 | $1,110,000 | +187.6% | 45,686 | +137.9% | 0.00% | – |
Q4 2018 | $386,000 | – | 19,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 1,136,416 | $1,049,367 | 0.10% |
Anson Funds Management LP | 129,795 | $119,853 | 0.02% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 60,000 | $55 | 0.01% |
Hudson Bay Capital Management LP | 274,300 | $253,289 | 0.00% |
UBS Group AG | 33 | $30 | 0.00% |
RHUMBLINE ADVISERS | 347 | $320 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $184 | 0.00% |
WELLS FARGO & COMPANY/MN | 132 | $122 | 0.00% |
NORTHERN TRUST CORP | 22,231 | $20,528 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |